Literature DB >> 10189052

Pregnancy experience in women who later developed oestrogen-related cancers (Denmark).

J Olsen1, H Storm.   

Abstract

OBJECTIVES: There has been speculation that women with oestrogen-related cancers have been exposed to high levels of oestrogen in earlier life and therefore also during their pregnancies prior to the disease. For this reason we examined signs of reproductive outcome related to oestrogen exposure such as twinning, sex ratio, birth weight and congenital malformation in women who later were diagnosed with breast cancer, endometrial or ovarian cancer.
METHODS: For 5213 children born to women who later developed breast cancer, 557 children born to women who later developed ovarian cancer and 173 children born to mothers with endometrial cancers we selected as a control four times as many newborns of mothers without these cancers after matching for mothers' parity, age, date of birth and hospital attended. All data were extracted from existing nationwide files. Most of the women's reproductive lives fell within the period of the birth registry from 1973 to 1993.
RESULTS: No differences in sex ratio, birth weight or malformation were found between the newborns to cancer or control mothers in any of the cancer groups studied. The only significant findings were less than expected births of twins to mothers who later developed cancer of the ovaries and a higher proportion of newborns with a birth weight over 4000 g in the cancer corpus uterus group.
CONCLUSION: Although the amount of information is limited for endometrial and ovarian cancers, we found no strong indication of elevated oestrogen levels during pregnancy.

Entities:  

Mesh:

Year:  1998        PMID: 10189052     DOI: 10.1023/a:1008831802805

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  14 in total

1.  Fetal growth and subsequent maternal risk of colorectal cancer.

Authors:  Casey Crump; Jan Sundquist; Weiva Sieh; Marilyn A Winkleby; Kristina Sundquist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-02       Impact factor: 4.254

2.  Offspring sex ratio at birth and maternal breast cancer risk: A case-control study and meta-analysis of literature.

Authors:  Mostafa Saadat
Journal:  EXCLI J       Date:  2010-07-26       Impact factor: 4.068

3.  Fetal growth and subsequent maternal risk of thyroid cancer.

Authors:  Casey Crump; Jan Sundquist; Weiva Sieh; Marilyn A Winkleby; Kristina Sundquist
Journal:  Int J Cancer       Date:  2015-10-05       Impact factor: 7.396

4.  Impact of Time Since Last Childbirth on Survival of Women with Premenopausal and Postmenopausal Breast Cancers.

Authors:  Nanthini Balakrishnan; Soo-Hwang Teo; Siamala Sinnadurai; Nanthini Thevi Bhoo Pathy; Mee-Hoong See; Nur Aishah Taib; Cheng-Har Yip; Nirmala Bhoo Pathy
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

Review 5.  Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature.

Authors:  Sarah Nechuta; Nigel Paneth; Ellen M Velie
Journal:  Cancer Causes Control       Date:  2010-03-12       Impact factor: 2.506

6.  Developmental and environmental origins of breast cancer: DDT as a case study.

Authors:  Barbara A Cohn
Journal:  Reprod Toxicol       Date:  2010-10-19       Impact factor: 3.143

7.  A population-based case-control study of fetal growth, gestational age, and maternal breast cancer.

Authors:  Sarah Nechuta; Nigel Paneth; Dorothy R Pathak; Joseph Gardiner; Glenn Copeland; Ellen M Velie
Journal:  Am J Epidemiol       Date:  2010-09-21       Impact factor: 4.897

8.  Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort.

Authors:  Lorelei A Mucci; Paul W Dickman; Mats Lambe; Hans-Olov Adami; Dimitrios Trichopoulos; Tomas Riman; Chung-Cheng Hsieh; Sven Cnattingius
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

9.  Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.

Authors:  Susan J Jordan; Renhua Na; Elisabete Weiderpass; Hans-Olov Adami; Kristin E Anderson; Piet A van den Brandt; Louise A Brinton; Chu Chen; Linda S Cook; Jennifer A Doherty; Mengmeng Du; Christine M Friedenreich; Gretchen L Gierach; Marc T Goodman; Vittorio Krogh; Fabio Levi; Lingeng Lu; Anthony B Miller; Susan E McCann; Kirsten B Moysich; Eva Negri; Sara H Olson; Stacey Petruzella; Julie R Palmer; Fabio Parazzini; Malcolm C Pike; Anna E Prizment; Timothy R Rebbeck; Peggy Reynolds; Fulvio Ricceri; Harvey A Risch; Thomas E Rohan; Carlotta Sacerdote; Leo J Schouten; Diego Serraino; Veronica W Setiawan; Xiao-Ou Shu; Todd R Sponholtz; Amanda B Spurdle; Rachael Z Stolzenberg-Solomon; Britton Trabert; Nicolas Wentzensen; Lynne R Wilkens; Lauren A Wise; Herbert Yu; Carlo La Vecchia; Immaculata De Vivo; Wanghong Xu; Anne Zeleniuch-Jacquotte; Penelope M Webb
Journal:  Int J Cancer       Date:  2020-11-17       Impact factor: 7.316

10.  Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role?

Authors:  R Troisi; K E Innes; J M Roberts; R N Hoover
Journal:  Br J Cancer       Date:  2007-08-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.